Funding
← Back to your selection

Andera Partners

Activity from announced rounds

Activity in this selectionEurope
Rounds participated in
3
Confirmed lead rounds
1
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$151.5M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Biotech2
Healthtech1

By country

France1
Germany1
Switzerland1

Rounds

3 in this selection
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Lead
Exciva

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

€51MSeries B
Role not disclosed